Clinical symptoms of hyperandrogenic women diagnosed with COVID-19
J Eur Acad Dermatol Venereol
.
2021 Feb;35(2):e101-e104.
doi: 10.1111/jdv.17004.
Epub 2020 Nov 8.
Authors
F A Cadegiani
1
2
,
R K Lim
3
,
A Goren
4
,
J McCoy
4
,
M Situm
5
,
M Kovacevic
5
,
S Vañó Galván
6
,
R Sinclair
7
,
A Tosti
8
,
C G Wambier
9
Affiliations
1
Department of Endocrinology, Federal University of São Paulo, São Paulo, Brazil.
2
Corpometria Institute, Brasília, Brazil.
3
Brown University, Providence, RI, USA.
4
Applied Biology, Inc. Irvine, CA, USA.
5
Department of Dermatology and Venereology, University Hospital Center "Sestre milosrdnice", Zagreb, Croatia.
6
Trichology Unit, Dermatology Department, Ramon y Cajal Hospital, IRYCIS, University of Alcala, Madrid, Spain.
7
Department of Medicine, University of Melbourne, Melbourne, Vic., Australia.
8
Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.
9
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA.
PMID:
33089570
DOI:
10.1111/jdv.17004
No abstract available
Publication types
Letter
MeSH terms
Adult
COVID-19 / complications*
COVID-19 / diagnosis
COVID-19 / epidemiology*
Case-Control Studies
Cross-Sectional Studies
Female
Humans
Hyperandrogenism / complications*